Efficient acute and chronic infection of stem cell-derived hepatocytes by hepatitis C virus.
carpentier et al.pdf
Open Access article
Data supplement 1
Data supplement 2
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractTranscriptional profiling revealed that HLCs constitutively express messenger RNA of RLRs, and members of the IFN pathway. Moreover, HLCs upregulated IFNs and canonical interferon-regulated genes (IRGs) upon transfection with the double-stranded RNA mimic poly(I:C). Infection of HLCs with Jc1-HCVcc produced only limited viral progeny. In contrast, infection with p100, a Jc1-derived virus population with enhanced replication fitness and partial resistance to IFN, resulted in robust yet transient viraemia. Viral titres declined concomitant with a peak of IRG induction. Addition of ruxolitinib, a JAK/STAT inhibitor, permitted chronic infection and raised p100 infectious virus titres to 1×105 FFU/mL. IRGs expression profiling in infected HLCs revealed a landscape of HCV-dependent transcriptional changes similar to HCV-infected primary human hepatocytes, but distinct from Huh-7.5 cells. Withdrawal of ruxolitinib restored innate immune responses and resulted in HCV clearance.
CitationGut. 2020 Feb 29. pii: gutjnl-2019-319354. doi: 10.1136/gutjnl-2019-319354.
AffiliationTWINCORE, Zentrum für Experimentelle und Klinische Infektionsforschung GmbH, Feodor-Lynen-Str. 7, 30625 Hannover, Germany.
PublisherBMJ Publishing Group
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
- Authors: Grünvogel O, Esser-Nobis K, Reustle A, Schult P, Müller B, Metz P, Trippler M, Windisch MP, Frese M, Binder M, Fackler O, Bartenschlager R, Ruggieri A, Lohmann V
- Issue date: 2015 Oct
- Hepatitis C virus-induced innate immune responses in human iPS cell-derived hepatocyte-like cells.
- Authors: Sakurai F, Kunito T, Takayama K, Hashimoto R, Tachibana M, Sakamoto N, Wakita T, Mizuguchi H
- Issue date: 2017 Oct 15
- Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
- Authors: Vazquez C, Tan CY, Horner SM
- Issue date: 2019 Dec 1
- Multi-step regulation of interferon induction by hepatitis C virus.
- Authors: Oshiumi H, Funami K, Aly HH, Matsumoto M, Seya T
- Issue date: 2013 Apr
- HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.
- Authors: Israelow B, Narbus CM, Sourisseau M, Evans MJ
- Issue date: 2014 Oct